Guillain-Barré syndrome after transplantation

References

• Seneviratne U. Guillain-Barre syndrome. Postgrad Med J 2000; 76: 774–782
   PubMed Web of Science ®Google Scholar
• Winer J B. Guillain-Barre syndrome. Mol Pathol 2001; 54: 381–385
   PubMedGoogle Scholar
• van der Meche F G, Visser L H, Jacobs B C, Endtz H P, Meulstee J, van Doorn P A. Guillain-Barre syndrome: multifactorial mechanisms versus defined subgroups. J Infect Dis 1997; 176(Suppl 2)S99–S102
   PubMed Web of Science ®Google Scholar
• Mailander V, Gleisner B, Blau I W, Thiel E. Guillain-Barre – Strohl syndrome unraveled as paraneoplastic syndrome of B-cell acute lymphoblastic leukemia in a patient with preceding common variable immunodeficiency syndrome with Evans syndrome. Leuk Lymphoma 2004; 45: 189–192
   PubMed Web of Science ®Google Scholar
• Vembu P, Al Shubaili A, Al Khuraibet A, Kreze O, Pandita R. Guillain-Barre syndrome in a case of acute lymphoblastic leukaemia. A case report. Med Principle Practices 2003; 12: 272–275
   PubMed Web of Science ®Google Scholar
• Aral Y Z, Gursel T, Ozturk G, Serdaroglu A. Guillain-Barre syndrome in a child with acute lymphoblastic leukemia. Pediatr Hematol Oncol 2001; 18: 343–346
   PubMed Web of Science ®Google Scholar
• Geetha N, Hussain B M, Lali V S, Nair M K, Kumar B S. Guillain-Barre syndrome occurring as a complication of acute nonlymphoblastic leukemia. Am J Med 1999; 107: 100–101
   PubMed Web of Science ®Google Scholar
• Rodrigues A, Monteiro A, Viana J, Macedo A, Graca F, Sena A. Acute non-lymphoblast leukaemia presenting as a Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1993; 56: 936–937
   PubMed Web of Science ®Google Scholar
• Phanthumchinda K, Intragumtornchai T, Kasantikul V. Guillain-Barre syndrome and optic neuropathy in acute leukemia. Neurology 1988; 38: 1324–1326
   PubMed Web of Science ®Google Scholar
• Norman M, Elinder G, Finkel Y. Vincristine neuropathy and a Guillain-Barre syndrome: a case with acute lymphatic leukemia and quadriparesis. Eur J Haematol 1987; 39: 75–76
   PubMed Web of Science ®Google Scholar
• D'Arena G, Vigliotti M L, Pizza V, Tartarone A, Volpe G, Iodice G, et al. Guillain-Barre syndrome complicating mobilization therapy in a case of B-cell chronic lymphocytic leukemia. Leuk Lymphoma 2004; 45: 1489–1490
   PubMed Web of Science ®Google Scholar
• Jackson M. Guillain-Barre syndrome in a patient with chronic lymphocytic leukaemia. Postgrad Med J 1993; 69: 832–833
   PubMed Web of Science ®Google Scholar
• Qureshi A I, Cook A A, Mishu H P, Krendel D A. Guillain-Barre syndrome in immunocompromised patients: a report of three patients and review of the literature. Muscle Nerve 1997; 20: 1002–1007
   PubMed Web of Science ®Google Scholar
• Moon J S, Souayah N. Guillain-Barre syndrome triggered by influenza vaccination in a recipient of liver transplant on FK506. Liver Transplant 2006; 12: 1537–1539
   PubMed Web of Science ®Google Scholar
• Kaushik P, Cohen A J, Zuckerman S J, Vatsavai S R, Pepper J S, Banda V R, et al. Miller fisher variant of Guillain-Barre syndrome requiring a cardiac pacemaker in a patient on tacrolimus after liver transplantation. Ann Pharmacother 2005; 39: 1124–1127
   PubMed Web of Science ®Google Scholar
• Echaniz-Laguna A, Battaglia F, Ellero B, Mohr M, Jaeck D. Chronic inflammatory demyelinating polyradiculoneuropathy in patients with liver transplantation. Muscle Nerve 2004; 30: 501–504
   PubMed Web of Science ®Google Scholar
• Colle I, Van Vlierberghe H, Troisi R, De Ridder K, Benoit D, de Hemptinne B, et al. Campylobacter-associated Guillain-Barre syndrome after orthotopic liver transplantation for hepatitis C cirrhosis: a case report. Hepatol Res 2002; 24: 205
   PubMed Web of Science ®Google Scholar
• Bulsara K R, Baron P W, Tuttle-Newhall J E, Clavien P A, Morgenlander J. Guillain-Barre syndrome in organ and bone marrow transplant patients. Transplantation 2001; 71: 1169–1172
   PubMed Web of Science ®Google Scholar
• El Sabrout R A, Radovancevic B, Ankoma-Sey V, Van Buren C T. Guillain-Barre syndrome after solid organ transplantation. Transplantation 2001; 71: 1311–1316
   PubMed Web of Science ®Google Scholar
• Bronster D J, Yonover P, Stein J, Scelsa S N, Miller C M, Sheiner P A. Demyelinating sensorimotor polyneuropathy after administration of FK506. Transplantation 1995; 59: 1066–1068
   PubMed Web of Science ®Google Scholar
• Taylor B V, Wijdicks E F, Poterucha J J, Weisner R H. Chronic inflammatory demyelinating polyneuropathy complicating liver transplantation. Ann Neurol 1995; 38: 828–831
   PubMed Web of Science ®Google Scholar
• Wilson J R, Conwit R A, Eidelman B H, Starzl T, Abu-Elmagd K. Sensorimotor neuropathy resembling CIDP in patients receiving FK506. Muscle Nerve 1994; 17: 528–532
   PubMed Web of Science ®Google Scholar
• Falk J A, Cordova F C, Popescu A, Tatarian G, Criner G J. Treatment of Guillain-Barre syndrome induced by cyclosporine in a lung transplant patient. J Heart Lung Transplant 2006; 25: 140–143
   PubMed Web of Science ®Google Scholar
• Adair J, Rose J, Alderson K. Inflammatory polyneuropathy after heart transplantation. Its association with antibodies to asialo-GM1 and sulfatide. Transplantation 1993; 56: 1597–1599
   PubMed Web of Science ®Google Scholar
• Baldwin R T, Pierce R R, Frazier O H. Guillain-Barre syndrome after heart transplantation. J Heart Lung Transplant 1992; 11: 817–819
   PubMed Web of Science ®Google Scholar
• Gentile S, Messina M, Rainero I, Lo G R, De Martino P, Pinessi L. Miller Fisher syndrome associated with Burkitt's lymphoma. Eur J Neurol 2006; 13: 430
   PubMed Web of Science ®Google Scholar
• Murali H R, Josephs K A, Wijdicks E F. Guillain-Barre syndrome in an immunocompromised patient and coccidioidomycosis infection. Rev Neurol Dis 2006; 3: 82–84
   PubMedGoogle Scholar
• de Maar E F, Kas-Deelen D M, de Jager A E, The H, Tegzess A M, van Son W J. Inflammatory demyelinating polyneuropathy in a kidney transplant patient with cytomegalovirus infection. Nephrol Dial Transplant 1999; 14: 2228–2230
   PubMed Web of Science ®Google Scholar
• Maccario M, Tarantino A, Nobile-Orazio E, Ponticelli C. Campylobacter jejuni bacteremia and Guillain-Barre syndrome in a renal transplant recipient. Transplant Int 1998; 11: 439–442
   PubMed Web of Science ®Google Scholar
• Bouza-Pineiro P, Pego R, Alonso A, de la F R, Martul E V. Guillain-Barre syndrome after renal transplantation: a case of clinical success with intravenous immunoglobulin therapy. Nephron 1996; 74: 223–224
   PubMedGoogle Scholar
• Donaghy M, Gray J A, Squier W, Kurtz J B, Higgins R M, Richardson A J, et al. Recurrent Guillain-Barre syndrome after multiple exposures to cytomegalovirus. Am J Med 1989; 87: 339–341
   PubMed Web of Science ®Google Scholar
• Bale J F, Jr, Rote N S, Bloomer L C, Bray P F. Guillain-Barre-like polyneuropathy after renal transplant: possible association with cytomegalovirus infection. Arch Neurol 1980; 37: 784
   PubMed Web of Science ®Google Scholar
• Drachman D A, Paterson P Y, Berlin B, Roguska J. Immunosuppression and the Guillain-Barre syndrome. Neurology 1970; 20: 390
   PubMed Web of Science ®Google Scholar
• Fujisaki G, Kami M, Murashige N, Kishi Y, Hori A, Chizuka A, et al. Guillain-Barre syndrome associated with rapid immune reconstitution following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2006; 37: 617–619
   PubMed Web of Science ®Google Scholar
• Hernandez-Boluda J C, Lis M J, Goterris R, Arbona C, Terol M J, Tormo M, et al. Guillain-Barre syndrome associated with cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Transplant Infect Dis 2005; 7: 93–96
   PubMed Web of Science ®Google Scholar
• Khan B, Hashmi K U, Ahmed P, Raza S, Hussain I, Malik H S, et al. Posttransplant Guillain Barre Syndrome. J Coll Physicians Surg Pak 2005; 15: 117–118
   PubMedGoogle Scholar
• Bitan M, Or R, Shapira M Y, Mador N, Resnick I B, Saleh N, et al. Early-onset Guillain-Barre syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantation. Clin Infect Dis 2004; 39: 1076–1078
   PubMed Web of Science ®Google Scholar
• Rodriguez V, Kuehnle I, Heslop H E, Khan S, Krance R A. Guillain-Barre syndrome after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 515–517
   PubMed Web of Science ®Google Scholar
• Nagashima T, Sato F, Chuma T, Mano Y, Sasaki I, Mori M, et al. Chronic demyelinating polyneuropathy in graft-versus-host disease following allogeneic bone marrow transplantation. Neuropathology 2002; 22: 1–8
   PubMed Web of Science ®Google Scholar
• Gonzalez M I, Caballero D, Lopez C, Alburquerque T, Hernandez R, de la L A, et al. Cerebral toxoplasmosis and Guillain-Barre syndrome after allogeneic peripheral stem cell transplantation. Transplant Infect Dis 2000; 2: 145–149
   PubMedGoogle Scholar
• Wen P Y, Alyea E P, Simon D, Herbst R S, Soiffer R J, Antin J H. Guillain-Barre syndrome following allogeneic bone marrow transplantation. Neurology 1997; 49: 1711–1714
   PubMed Web of Science ®Google Scholar
• Schwarzer A, Schulze E, Leiblein S, Krahl R, Kubel M, Bartram C, et al. Guillain Barre syndrome, a possible side effect of buffy coat transfusion and IFN-α therapy in relapsed CML after bone marrow transplantation. Ann Oncol 1995; 6: 617
   PubMed Web of Science ®Google Scholar
• Hagensee M E, Benyunes M, Miller J A, Spach D H. Campylobacter jejuni bacteremia and Guillain-Barre syndrome in a patient with GVHD after allogeneic BMT. Bone Marrow Transplant 1994; 13: 349–351
   PubMed Web of Science ®Google Scholar
• Liedtke W, Quabeck K, Beelen D W, Straeten V, Schaefer U W. Recurrent acute inflammatory demyelinating polyradiculitis after allogeneic bone marrow transplantation. J Neurol Sci 1994; 125: 110–111
   PubMed Web of Science ®Google Scholar
• Perry A, Mehta J, Iveson T, Treleaven J, Powles R. Guillain-Barre syndrome after bone marrow transplantation. Bone Marrow Transplant 1994; 14: 165–167
   PubMed Web of Science ®Google Scholar
• Eliashiv S, Brenner T, Abramsky O, Shahin R, Agai E, Naparstek E, et al. Acute inflammatory demyelinating polyneuropathy following bone marrow transplantation. Bone Marrow Transplant 1991; 8: 315–317
   PubMed Web of Science ®Google Scholar
• Adams C, August C S, Maguire H, Sladky J T. Neuromuscular complications of bone marrow transplantation. Pediatr Neurol 1995; 12: 58–61
   PubMed Web of Science ®Google Scholar
• Maguire H, August C, Sladky J. Chronic inflammatory demyelinating polyneuropathy: a previously unreported complication of bone marrow transplanation. Neurology 1989; 39(Suppl)410
   Google Scholar
• Lind M J, McWilliam L, Jip J, Scarffe J H, Morgenstern G R, Chang J. Cyclosporin associated demyelination following allogeneic bone marrow transplantation. Hematol Oncol 1989; 7: 49–52
   PubMed Web of Science ®Google Scholar
• Johnson N T, Crawford S W, Sargur M. Acute acquired demyelinating polyneuropathy with respiratory failure following high-dose systemic cytosine arabinoside and marrow transplantation. Bone Marrow Transplant 1987; 2: 203–207
   PubMed Web of Science ®Google Scholar
• Khatri B O, Flamini J R, Baruah J K, Dobyns W B, Konkol R J. Plasmapheresis with acute inflammatory polyneuropathy. Pediatr Neurol 1990; 6: 17–19
   PubMed Web of Science ®Google Scholar
• Janssen J J, Tissingh G, Ossenkoppele G J. Guillain-Barre syndrome after autologous peripheral blood stem cell transplantation for CML. Eur J Haematol 1999; 63: 358–359
   PubMed Web of Science ®Google Scholar
• Griggs J J, Commichau C S, Rapoport A P, Griggs R C. Chronic inflammatory demyelinating polyneuropathy in non-Hodgkin's lymphoma. Am J Hematol 1997; 54: 332–334
   PubMed Web of Science ®Google Scholar
• Yoshiyama Y, Nakajima M, Kuwabara S, Kawano E. Demyelinating brachial neuropathy complicating syngeneic graft-versus-host disease. Neurology 1997; 48: 287–288
   PubMed Web of Science ®Google Scholar
• Mudad R, Hussein A, Peters W P. Guillain-Barre syndrome following autologous bone marrow transplantation. Am J Clin Oncol 1995; 18: 167–169
   PubMed Web of Science ®Google Scholar
• Myers S E, Williams S F. Guillain-Barre syndrome after autologous bone marrow transplantation for breast cancer: report of two cases. Bone Marrow Transplant 1994; 13: 341–344
   PubMed Web of Science ®Google Scholar
• Bashir R M, Bierman P, McComb R. Inflammatory peripheral neuropathy following high dose chemotherapy and autologous bone marrow transplantation. Bone Marrow Transplant 1992; 10: 305–306
   PubMed Web of Science ®Google Scholar
• Patchell R A. Neurological complications of organ transplantation. Ann Neurol 1994; 36: 688–703
   PubMed Web of Science ®Google Scholar
• Patchell R A, White C L, III, Clark A W, Beschorner W E, Santos G W. Neurologic complications of bone marrow transplantation. Neurology 1985; 35: 300–306
   PubMed Web of Science ®Google Scholar
• Drachman D A, Paterson P Y, Berlin B S, Roguska J. Immunosuppression and the Guillain-Barre syndrome. Arch Neurol 1970; 23: 385–393
   PubMed Web of Science ®Google Scholar
• Openshaw H, Slatkin N E. Clinical spectrum of demyelinating polyneuropathy after bone marrow transplantation. Neurology 1994; 44: A277
   Web of Science ®Google Scholar
• Jiang G X, Cheng Q, Ehrnst A, Link H, Pedro-Cuesta J. Guillain-Barre syndrome in Stockholm County, 1973 – 1991. Eur J Epidemiol 1997; 13: 25–32
   PubMed Web of Science ®Google Scholar
• Hankey G J. Guillain-Barre syndrome in Western Australia, 1980 – 1985. Med J Aust 1987; 146: 130–133
   PubMed Web of Science ®Google Scholar
• McLean M, Duclos P, Jacob P, Humphreys P. Incidence of Guillain-Barre syndrome in Ontario and Quebec, 1983 – 1989, using hospital service databases. Epidemiology 1994; 5: 443–448
   PubMed Web of Science ®Google Scholar
• Randall T. The gender gap in selection of cardiac transplantation candidates: bogus or bias?. JAMA 1993; 269: 2718–2720
   PubMed Web of Science ®Google Scholar
• Peltier A C, Russell J W. Recent advances in drug-induced neuropathies. Curr Opin Neurol 2002; 15: 633–638
   PubMed Web of Science ®Google Scholar
• Ayres R C, Dousset B, Wixon S, Buckels J A, McMaster P, Mayer A D. Peripheral neurotoxicity with tacrolimus. Lancet 1994; 343: 862–863
   PubMed Web of Science ®Google Scholar
• Winer J B, Hughes R A, Anderson M J, Jones D M, Kangro H, Watkins R P. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 1988; 51: 613–618
   PubMed Web of Science ®Google Scholar
• Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Lancet 1997; 349: 225–230
   PubMed Web of Science ®Google Scholar
• van der Meche F G, Schmitz P I. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barre Study Group. N Engl J Med 1992; 326: 1123–1129
   PubMed Web of Science ®Google Scholar